Benzinga | Sep 29, 2020 06:47AM EDT

HC Wainwright & Co. Maintains Buy on Checkpoint Therapeutics, Raises Price Target to $17

HC Wainwright & Co. maintains Checkpoint Therapeutics (NASDAQ:CKPT) with a Buy and raises the price target from $15 to $17.